RESMED INC News
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
see moreRESMED INC Market News
4d
ResMed's Stock Journey: Recovery and Institutional Confidence Despite Market Challenges
- ResMed's stock experiences fluctuations amid recent market developments.
9d
ResMed's Stock Performance Amidst Recent Market Movements
ResMed's stock experiences fluctuations amid recent market developments.
16d
ResMed's Stock Decline Amid Analyst Downgrades and Market Volatility
ResMed's stock faces decline due to analyst downgrades and market volatility.
23d
ResMed's Strategic Divestiture of MatrixCare and Market Response
ResMed sells MatrixCare to Frazier Healthcare; stock reacts to divestiture.
29d
ResMed's Stock Performance Amidst Industry Developments
ResMed's stock faces challenges amid industry trends and analyst ratings.
26 May at 14:42
ResMed Falls to 52-Week Low After Q3 Outlook Shift
ResMed shares dropped to a 52-week low after Q3 results and a cautious forward outlook, compounded by a CFO transition. This article summarizes the quarter, guidance specifics, and concrete investor implications for RMD.
19 May at 14:42
ResMed RMD: Oura Deal and Q3 Results Impact Today!
ResMed’s recent Oura partnership and fiscal Q3 report moved markets this week. The wearable integration expands patient reach while an unchanged outlook and CFO transition pressured RMD shares despite solid revenue, margin gains, and a dividend.